Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity
Abstract Osteosarcoma is the most common primary bone tumor, with a poor prognosis owing to the lack of efficient molecular-based targeted therapies. Previous studies have suggested an association between CD151 and distinct consequences in osteosarcoma tumorigenicity. However, the potential of CD151...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2022-10-01
|
| Ráidu: | Cell & Bioscience |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s13578-022-00900-9 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|